Biobank: ATBC Study (Finland): Difference between revisions
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
'''Date range:''' [[dataStart::1985]] - [[dataEnd::1993]] | '''Date range:''' [[dataStart::1985]] - [[dataEnd::1993]] | ||
'''Cancer areas of interest:''' [[hasCancerType::C00-D48: All neoplasms]]. [https://atbcstudy.cancer.gov/ | '''Cancer areas of interest:''' [[hasCancerType::C00-D48: All neoplasms]]. [https://atbcstudy.cancer.gov/docs/frequency_cancersite_byyear_13.2.2.2020-03-26.pdf Click here to learn more]. | ||
'''Data access:''' [[dataAvailability::not publicly available]]. [https:// | '''Data access:''' [[dataAvailability::not publicly available]]. [https://atbcstudy.cancer.gov/ Click here to access]. Instructions to request data for restricted content [[hasDataAccessInstructions::[https://thl.fi/en/web/thl-biobank/for-researchers/application-process]]]. | ||
'''Contact information:''' Information [https://thl.fi/en/web/thl-biobank/for-researchers/sample-collections/atbc-study]. | '''Contact information:''' Information [https://thl.fi/en/web/thl-biobank/for-researchers/sample-collections/atbc-study]. | ||
Revision as of 18:54, 13 May 2024
Go back to Finland page
Primary purpose: Store the sample collection and data information of participants from the study "The alpha-tocopherol, beta-carotene lung cancer prevention study", which was a randomized, double-blinded, placebo-controlled trial testing whether alpha-tocopherol and/or beta-carotene supplements can reduce the incidence of lung cancer and other cancers.
Sponsor, manager or home institution: THL Biobank.
Type of information: Data Dictionary: ATBC Study. Click here to learn more.
Data level: patient level.
Number of records: About 29,000 sample donors.
Date range: 1985 - 1993
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Data access: not publicly available. Click here to access. Instructions to request data for restricted content [1].
Contact information: Information [2].
